a public good project by the
Synthesis
Company
of California

© 2026

Annalisa Chiarenza | doi.page

0 works0 citations0 h-index

Annalisa Chiarenza

University of Catania(IT)

Publications by Year

Research Areas

Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Chronic Myeloid Leukemia Treatments, Immune cells in cancer

Most-Cited Works

→ Analysis of the coding genome of diffuse large B-cell lymphoma(2011)960 cited
→ Inactivating mutations of acetyltransferase genes in B-cell lymphoma(2011)928 cited
→ COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus(2020)274 cited
→ Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia(2015)214 cited
→ CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia(2009)140 cited
→ Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma(2017)135 cited

→ Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)(2016)

92 cited

→ Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia(2018)92 cited

→ Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy(2014)91 cited

→ Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study(2021)87 cited